Recent Research and Knowledge on Treatment for Hepatitis B
Journal of Bacteriology and Virology
; : 175-180, 2020.
Article
en En
| WPRIM
| ID: wpr-891210
Biblioteca responsable:
WPRO
ABSTRACT
Hepatitis B virus (HBV) infection is a major public health problem, with some 250 million people currently at high risk of developing chronic liver diseases. The current antiviral treatment for chronic hepatitis B (CHB) is effective in controlling viral replication but fails to achieve a complete cure. Since the identification of sodium taurocholate cotransport polypeptide (NTCP) as an HBV receptor, anti-HBV drugs targeting viral entry, capsid assembly, cccDNA, transcription, and secretion have been developed. In this paper, the potential inhibitors in various steps of the HBV life cycle are summarized.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
En
Revista:
Journal of Bacteriology and Virology
Año:
2020
Tipo del documento:
Article